Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains. Issue 51 (12th December 2016)

• Record Type: Journal Article
• Authors: Condit, Richard C.; Williamson, Anna-Lise; Sheets, Rebecca; Seligman, Stephen J.; Monath, Thomas P.; Excler, Jean-Louis; Gurwith, Marc; Bok, Karin; Robertson, James S.; Kim, Denny; Michael Hendry, R.; Singh, Vidisha; Mac, Lisa M.; Chen, Robert T.
• Is Part Of: Vaccine. Volume 34:Issue 51(2016)
• Page Start: 6610
• Page End: 6616
• Publication Date: 2016-12-12
• Subjects: Live viral vaccines -- Vaccines -- Vaccine safety -- Potential for recombination -- Virus recombination -- Vaccine manufacturing -- Brighton Collaboration; Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2016.04.060
• Languages: English
• ISSNs: 0264-410X

Abstract

Abstract: In 2003 and 2013, the World Health Organization convened informal consultations on characterization and quality aspects of vaccines based on live virus vectors. In the resulting reports, one of several issues raised for future study was the potential for recombination of virus-vectored vaccines with wild type pathogenic virus strains. This paper presents an assessment of this issue formulated by the Brighton Collaboration. To provide an appropriate context for understanding the potential for recombination of virus-vectored vaccines, we review briefly the current status of virus-vectored vaccines, mechanisms of recombination between viruses, experience with recombination involving live attenuated vaccines in the field, and concerns raised previously in the literature regarding recombination of virus-vectored vaccines with wild type virus strains. We then present a discussion of the major variables that could influence recombination between a virus-vectored vaccine and circulating wild type virus and the consequences of such recombination, including intrinsic recombination properties of the parent virus used as a vector; sequence relatedness of vector and wild virus; virus host range, pathogenesis and transmission; replication competency of vector in target host; mechanism of vector attenuation; additional factors potentially affecting virulence; and circulation of multiple recombinant vectors in the same target population. Finally, we present some guiding principles for vector design and testing intended to anticipate and mitigate the potential for and consequences of recombination of virus-vectored vaccines with wild type pathogenic virus strains.